In our study, pharmacological inhibition of Chek1/2 by Prexasertib and AZD7762, two different inhibitors proven safe in clinical trials, rendered gliomas susceptible to PD-1 blockade in glioma models. Here, CHEK1 is linked to central nervous system cancer.